[Effectiveness of botulinum toxin A in the treatment of gustatory sweating].

Nervenarzt

Klinik und Poliklinik für Mund-, Kiefer- und Gesichtschirurgie, Medizinische Hochschule Hannover, Carl-Neuberg-Strasse 1, 30625 Hannover.

Published: October 2001

Frey's syndrome is present in almost all patients after parotidectomy. Gustatory sweating reduces quality of life. Injections of botulinum toxin A have recently been described as effective. This study was designed to evaluate the efficacy of this new treatment. Nineteen patients with severe gustatory sweating following superficial parotidectomy were treated. One unit/cm2 botulinum toxin A was injected intracutaneously into the affected area once. Minor's starch iodine test was performed to prove the outcome of therapy 4 weeks later. Eight patients lost their sweating. However, another seven patients had some blue spots on their cheeks. In four patients whose sweating had extended beyond the hairline, remnants of gustatory sweating showed up. Overall, the affected area of gustatory sweating could be reduced by botulinum toxin A from an average of 31 cm2 before treatment to 4 cm2 after treatment. Although there were some remnants of sweating in a few patients, Frey's syndrome was gone in all cases. No side effects could be observed. Intracutaneous injections of botulinum toxin A are highly effective and safe in treatment of gustatory sweating.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s001150170035DOI Listing

Publication Analysis

Top Keywords

botulinum toxin
20
gustatory sweating
20
treatment gustatory
8
frey's syndrome
8
sweating
8
injections botulinum
8
sweating patients
8
cm2 treatment
8
gustatory
6
patients
6

Similar Publications

Impact of Proposed Medicare Policy Changes for Botulinum Toxin Coverage on Hemifacial Spasm and Facial Dystonia.

Facial Plast Surg Aesthet Med

January 2025

Division of Facial Plastic and Reconstructive Surgery, Department of Otolaryngology-Head & Neck Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, USA.

View Article and Find Full Text PDF

Background: Anti-Activin Receptor Type IIA and Type IIB antibody (αActRIIA/IIB ab) is a recently developed drug class that targets the activin receptor signalling pathway. Inhibition of receptor ligands (activins, myostatin, growth differentiation factor 11, etc.) can lead to skeletal muscle hypertrophy, bone formation, and increased haematopoiesis.

View Article and Find Full Text PDF

Unlabelled: Chronic migraine and cervicalgia have a significant impact on the quality of life of patients. Traditional treatment methods do not always provide long-term improvement, which necessitates the search for alternative methods of therapy. Electrotherapy and botulinum therapy are considered as promising methods for reducing pain and improving the general condition of patients.

View Article and Find Full Text PDF

Origin and In-Office Treatment of Retrograde Cricopharyngeus Dysfunction.

JAMA Otolaryngol Head Neck Surg

January 2025

Department of Otolaryngology-Head and Neck Surgery, Foch Hospital, School of Medicine, Paris Saclay University, Paris, France.

Importance: Retrograde cricopharyngeus dysfunction (R-CPD) is an emerging disorder associated with disabling symptoms. The origin of R-CPD remains unknown.

Objective: To investigate the development of symptoms, diagnosis approach, and therapeutic outcomes of R-CPD in patients treated with in-office botulinum toxin injection (BTI) into the cricopharyngeus.

View Article and Find Full Text PDF

Background: Non-motor symptoms, including depression, anxiety, sleep disturbances, pain and cognitive dysfunction, are a much more important predictor of quality of life than the severity of dystonia.

Objectives: To assess the effect of Botulinum toxin on non-motor symptoms and quality of life in patients with adult-onset idiopathic focal dystonia.

Methods: Patients aged > 18 years diagnosed with idiopathic focal dystonia were recruited in this longitudinal cohort study.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!